Undercarboxylated osteocalcin may be an attractive marker of teriparatide treatment in rheumatoid arthritis patients.
Department of Internal Medicine, Center for Rheumatic Diseases, Dohgo Spa Hospital, 21-21 Otsu Dohgo-Himezuka, Matsuyama, Ehime, 790-0858, Japan, sho-mokuda@hiroshima-u.ac.jp.
S
S
Mokuda
D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D019379:Teriparatide / Q000008:administration & dosage*
D050071:Bone Density Conservation Agents; D019379:Teriparatide